Artelo Biosciences, Inc. (ARTL)
5.85
-0.13
(-2.17%)
USD |
NASDAQ |
Sep 10, 14:17
Artelo Biosciences Total Assets (Quarterly) : 6.459M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.459M |
| March 31, 2026 | 12.52M |
| December 31, 2025 | 2.801M |
| September 30, 2025 | 4.267M |
| June 30, 2025 | 4.357M |
| March 31, 2025 | 3.515M |
| December 31, 2024 | 4.698M |
| September 30, 2024 | 7.136M |
| June 30, 2024 | 8.326M |
| March 31, 2024 | 10.35M |
| December 31, 2023 | 13.04M |
| September 30, 2023 | 15.50M |
| June 30, 2023 | 16.88M |
| March 31, 2023 | 18.48M |
| December 31, 2022 | 20.42M |
| September 30, 2022 | 22.42M |
| June 30, 2022 | 24.40M |
| March 31, 2022 | 26.70M |
| August 31, 2021 | 12.64M |
| Date | Value |
|---|---|
| May 31, 2021 | 12.34M |
| February 28, 2021 | 13.44M |
| November 30, 2020 | 9.539M |
| August 31, 2020 | 4.377M |
| May 31, 2020 | 3.494M |
| February 29, 2020 | 4.152M |
| November 30, 2019 | 5.548M |
| August 31, 2019 | 6.483M |
| May 31, 2019 | 1.153M |
| February 28, 2019 | 0.4843M |
| November 30, 2018 | 0.1654M |
| August 31, 2018 | 0.397M |
| May 31, 2018 | 0.401M |
| February 28, 2018 | 0.5411M |
| November 30, 2017 | 0.4303M |
| August 31, 2017 | 0.5743M |
| May 31, 2017 | 0.2278M |
| February 28, 2017 | 0.0135M |
| November 30, 2016 | 0.0036M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.462M |
| Shareholders Equity (Quarterly) | 4.997M |
| Debt to Equity Ratio | 0.0098 |
| Current Ratio | 3.004 |
| Net Debt Paydown Yield | 0.02% |